Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 13, 2021JAMA Network OpenOpen Access

Hydroxyurea Use After Transitions of Care Among Young Adults With Sickle Cell Disease and Tennessee Medicaid Insurance

View Full Paper
Ask AI
Bookmark
Share

Authors

JMJoacy G. MathiasUniversity of North Carolina at Chapel HillVNVal NolanSt. Jude Children's Research HospitalLKLisa M. KlesgesWashington University in St. Louis

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mathias et al. (2021) studied this question.

synapsesocial.com/papers/6ab5f9c67bb3766a626cd2e9https://doi.org/10.1001/jamanetworkopen.2021.28971
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Hydroxyurea use during pregnancy: A case report in sickle cell disease and review of the literature1999 · 67 citations
  2. 2Hydroxyurea for children with sickle cell anemia: Prescribe it early and often2019 · 23 citations
  3. 3Hydroxyurea Use for Sickle Cell Disease Among Medicaid-Enrolled Children2019 · 63 citations
  4. 4Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study2018 · 82 citations
  5. 5Cost‐effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease2010 · 47 citations